| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lenalidomide | FAERS: 233 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 2 | Thalidomide | FAERS: 51 | US FAERS | |
| 3 | pomalidomide | FAERS: 44 | US FAERS | |
| 4 | Isotretinoin | FAERS: 5 | US FAERS | |
| 5 | Norgestrel | FAERS: 5 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 6 | etonogestrel | FAERS: 4 | US FAERS | |
| 7 | Methotrexate | FAERS: 3 | US FAERS | |
| 8 | Copper | FAERS: 2 | US FAERS | |
| 9 | Alprazolam | FAERS: 1 | US FAERS | |
| 10 | Bortezomib | FAERS: 1 | US FAERS | |
| 11 | NuvaRing | FAERS: 1 | US FAERS | |
| 12 | PCI 32765 | FAERS: 1 | US FAERS | |
| 13 | Qlaira | FAERS: 1 | US FAERS | |
| 14 | brexpiprazole | FAERS: 1 | US FAERS | |
| 15 | histrelin | FAERS: 1 | US FAERS | |
| 16 | testosterone undecanoate | FAERS: 1 | US FAERS | |
| 17 | ulipristal acetate | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.